A cutting edge paper from three cannabis friendly medical professionals—Dustin Sulak, Russel Saneto, and Bonni Goldstein—outlines case reports and the applications of cannabis medicine for epilepsy and seizure disorders.
Project CBD exposes fraud and financial interests behind misleading report suggesting that CBD converts to THC in the stomach.
Misinformation can masquerade as science, especially when it comes to cannabis. Adrian Devitt-Lee highlights how analysis can be skewed for a variety of factors and gives insight on how to spot faulty research data.
A recent study finds that painkiller abuse and overdose are lower in states with medical marijuana laws on the books.
The 2016 meeting of the International Cannabinoid Research Society focused on the latest research in cannabinoid studies and the endocannabinoid system.
New scientific data shows that CBD interacts directly with the CB1 cannabinoid receptor in ways that are therapeutically relevant while modulating the psychoactive effects of THC. CBD lowers the ceiling on the ability of THC and endogenous cannabinoids to stimulate CB1. Cannabidiol is a profound mood-altering substance, even if it may not have a “high”.
A recent Care by Design survey of 300 patients suggests that cannabis is better than Big Pharma meds for PTSD issues.
Chronic marijuana use by young teens was not linked with mental or physical disorders more than two decades later, a new study found.